Erlotinib Hydrochloride [erlotinib]
topical
93
- Terms
-
erlotinib hydrochlorid
Tarceva
-
11C-erlotinib
CP 358,774
CP 358774
CP-358,774
CP-358774
Erlotinib
Erlotinib HCl
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
OSI-774
Tarceva
Persistent link
https://www.medvik.cz/link/D000069347
Definition
A quinazoline derivative and ANTINEOPLASTIC AGENT that functions as a PROTEIN KINASE INHIBITOR for EGFR associated tyrosine kinase. It is used in the treatment of NON-SMALL CELL LUNG CANCER.
- DUI
- D000069347 MeSH Browser
- CUI
- M0493669
- History note
- 2016 (1999)
- Public note
- 2016; ERLOTINIB HYDROCHLORIDE was indexed under QUINAZOLINES 1999-2015
Allowable subheadings
- AD
- administration & dosage 25
- AE
- adverse effects 18
- AG
- agonists
- AA
- analogs & derivatives 1
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood 1
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism 1
- PK
- pharmacokinetics 4
- PD
- pharmacology 13
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 52
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records